Lv13
72 积分 2025-11-09 加入
Interferon-α in acute myeloid leukemia: an old drug revisited
5小时前
已完结
Positron Emission Tomography–Guided Therapy of Aggressive Non-Hodgkin Lymphoma: Standard of Care After the PETAL Study?
1天前
已完结
Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee
1天前
已完结
Disseminated Magnusiomyces clavatus ( Geotrichum clavatum ) infection following allogenic stem cell transplantation: a case report
17天前
已完结
Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients
24天前
已完结
Clinical Experience With Venetoclax‐Based Combinations for Relapsed/Refractory or MRD ‐Positive NPM1 ‐Mutated Acute Myeloid Leukemia
1个月前
已完结
How we treat primary immune thrombocytopenia in adults
1个月前
已完结
Genetic and Phenotypic Correlates of Clinical Outcomes with Venetoclax in Acute Myeloid Leukemia: The GEN-PHEN-VEN Study
1个月前
已完结
Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study
1个月前
已完结
皖公网安备34019202002308
